Your browser doesn't support javascript.
loading
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population.
Kemnade, Jan O; Florez, Marcus; Sabichi, Anita; Zhang, Jun; Jhaveri, Pavan; Chen, George; Chen, Albert; Miller-Chism, Courtney; Shaun, Bulsara; Hilsenbeck, Susan G; Hernandez, David J; Skinner, Heath D; Sandulache, Vlad C.
Afiliación
  • Kemnade JO; Hematology Oncology Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States; Department of Internal Medicine, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, United States.
  • Florez M; Program in Translational Biology and Molecular Medicine, Baylor College of Medicine, Houston, TX, United States.
  • Sabichi A; Hematology Oncology Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States; Department of Internal Medicine, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, United States.
  • Zhang J; Department of Internal Medicine, Section of Hematology/Oncology, Houston Methodist Hospital, Houston, TX, United States.
  • Jhaveri P; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, United States.
  • Chen G; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, United States; Radiation Oncology Section, Diagnostic and Therapeutic CareLine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
  • Chen A; Department of Radiation Oncology, Baylor College of Medicine, Houston, TX, United States; Radiation Oncology Section, Diagnostic and Therapeutic CareLine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
  • Miller-Chism C; Department of Internal Medicine, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, United States.
  • Shaun B; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
  • Hilsenbeck SG; Department of Internal Medicine, Section of Hematology/Oncology, Baylor College of Medicine, Houston, TX, United States; Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX, United States.
  • Hernandez DJ; Bobby R. Alford Department of Otolaryngology- Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States; ENT Section, Operative CareLine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States.
  • Skinner HD; Department of Radiation Oncology, UPMC Hillman Cancer Center, Pittsburgh, PA, United States.
  • Sandulache VC; Bobby R. Alford Department of Otolaryngology- Head and Neck Surgery, Baylor College of Medicine, Houston, TX, United States; ENT Section, Operative CareLine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX, United States; Center for Translational Research on Inflammatory Diseases, Mi
Oral Oncol ; 145: 106536, 2023 10.
Article en En | MEDLINE | ID: mdl-37562095
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de Cabeza y Cuello / Metformina Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de Cabeza y Cuello / Metformina Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Idioma: En Revista: Oral Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article